Kidney cancer Doctors Abroad — Page 2

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Serkan Keskin is a premier medical oncologist at Memorial Şişli Hospital who ranked first in Turkey's national medical oncology proficiency exams.

• Specialises in immunotherapy and targeted therapy to attack kidney cancer cells with precision
• Uses chemotherapy protocols tailored to the specific stage and subtype of the tumour
• Member of the American Society of Clinical Oncology (ASCO)
• Awarded for excellence in cancer research at the National Cancer Congress
• Fellowship trained at the Istanbul University Institute of Oncology

Professor Yesim Yildirim completed specialist immunotherapy training at London's Mount Vernon Cancer Centre, focusing specifically on kidney cancer and melanoma clinics.

• Specialises in immunotherapy and targeted therapies that use the body's immune system to attack cancer cells
• Holds an ESMO certification, the gold standard for medical oncology expertise in Europe
• Serves as a Professor at Halic University, teaching newer generations of oncologists
• Co-authored the 'Handbook of Advanced Cancer Care Treatment' and 80 other scientific publications

Dr Rahib Hasanov provides personalised kidney cancer care at Hisar Hospital Intercontinental, using targeted therapies and immunotherapies to treat urogenital tumours.

• Trained at the world-renowned Houston Methodist Hospital in Texas, USA
• Specialises in 'smart drugs' that target cancer cells while sparing healthy tissue
• Completed a medical oncology fellowship at Marmara University Faculty of Medicine
• Uses immunotherapy to help the immune system recognise and destroy kidney tumours
• Treats a high volume of international patients from Europe and the Middle East

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Mehmet Dogu Canoglu is a radiation oncologist at Anadolu Medical Center in Istanbul. He specializes in precise tumor targeting using MR Linac and CyberKnife technologies. Dr. Canoglu trained at Kocaeli University. He previously served at Medipol Mega University Hospital. He treats various cancers, including complex brain, prostate, and lung tumors.

• Expert in Varian TrueBeam and Trilogy radiation delivery systems.
• Performs stereotaxic radiosurgery and targeted radiotherapy for sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.
• Treats patients at a clinic ranked among the world's top 10 for medical tourism.

Professor Sezer Saglam is a leading medical oncologist at Istanbul Florence Nightingale Hospital with specialised training in both oncology and hemodialysis.

• Specialises in systemic therapy and medical management for advanced renal malignancies
• Offers targeted therapies that focus on specific cancer molecules to slow tumour growth
• Holds rare dual qualifications in oncology and hemodialysis for complex kidney cases
• Active member of the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Tahsin Ozadli is a medical oncology specialist at Valued Med Hub Hospitals with deep expertise in managing gastrointestinal and metabolic-related malignancies.

• Specialises in medical oncology at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Focuses on systemic treatments for cancers affecting the digestive and urinary systems
• Published clinical research on oncology outcomes and treatment efficacy in Turkey
• Expertise includes managing complex cases across several major regional training hospitals

Dr Saban Sec serves as a national representative for the Turkish Medical Oncology Association, where he leads efforts in managing complex urogenital cancers.

• Specialises in urogenital cancers, including malignant tumours of the kidney and bladder
• Uses targeted systemic therapies to manage both localized and metastatic kidney cancer cases
• Trained at Istanbul University Prof Dr Cemil Tascioglu City Hospital, a major centre for oncology research
• Contributes to international oncology research focusing on prognostic factors and patient survival rates

Professor Turkan Ozturk Topcu is a medical oncology specialist at Valued Med Hub Hospitals who trained at the world-renowned MD Anderson Cancer Center in the USA.

• Specialises in medical oncology for kidney and urological cancers
• Trained at Moffitt Cancer Center, a top American facility for cancer research
• Completed a clinical programme at Sunnybrook Odette Cancer Centre in Canada
• Uses systemic therapies to manage both early and advanced renal tumours
• Fellow of the Karadeniz Technical University Faculty of Medicine

Associate Professor Yusuf Acikgoz brings high-level expertise from The Ohio State University to his role leading medical oncology at Lokman Hekim University.

• Specialises in systemic therapies for kidney cancer including immunotherapy and targeted drug regimes
• Served as an investigator on major Phase III global clinical trials for new cancer treatments
• Completed specialised immuno-oncology training with the Central European Cooperative Oncology Group in Vienna
• Active member of the American Society of Clinical Oncology since 2022
• Recognised for clinical research involving human subjects protection and laboratory animal research standards